Paul Goodson | executive |
Wenbin Jiang | executive |
William McCombe | executive |
Tejas Savant | analyst |
David Westenberg | analyst |
Mason Carrico | analyst |
Jacqueline Kisa | analyst |
Thank you for standing by. My name is Liz, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Cytek Biosciences First Quarter 2024 Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Paul Goodson, Investor Relations. Please go ahead.